Analysts Offer Insights on Healthcare Companies: Soligenix (SNGX) and Boston Scientific (BSX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Soligenix (SNGX – Research Report) and Boston Scientific (BSX – Research Report) with bullish sentiments.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Soligenix (SNGX)
In a report released today, James Molloy from Alliance Global Partners maintained a Buy rating on Soligenix, with a price target of $10.00. The company’s shares closed last Thursday at $1.09.
According to TipRanks.com, Molloy ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Soligenix has an analyst consensus of Moderate Buy, with a price target consensus of $10.00.
See the top stocks recommended by analysts >>
Boston Scientific (BSX)
In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Boston Scientific, with a price target of $110.00. The company’s shares closed last Thursday at $73.58.
According to TipRanks.com, Wise is a 1-star analyst with an average return of
Currently, the analyst consensus on Boston Scientific is a Strong Buy with an average price target of $108.14, a 47.4% upside from current levels. In a report issued on February 4, TipRanks – DeepSeek also upgraded the stock to Buy with a $101.00 price target.
